Clinical trial of Amruta Guggulu in the management of Diabetes

An open labeled Randomized controlled trial of Amruta Guggulu as an add-on effect in the management of Madhumeha.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/030157

Enrollment

Registered

2020-12-31

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Amruta Gugulu: 500mg twice a day with koshna Jal 3 months duration Control Intervention1: Conventional anti diabetic drug: As prescribed by physician with koshna Jal 3 months duration

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group - between 30 years to 60 years. 2. Gender - Male and Female both will be included. 3. A known Diabetic on treatment and newly diagnosed Diabetes. 4. Patient with fasting blood sugar up to 250 mg% and post prandial blood sugar up to 350 mg%. 5. Patient having HbA1C upto 10. 6. If the patient is taking Ayurvedic medicine for Madhumeha, Washout period for them will be days.

Exclusion criteria

Exclusion criteria: 1. Patients with fasting blood sugar above 250 mg% and post prandial blood sugar above 350mg%. 2. Patient who is already taking Ayurvedic management for Madhumeha. 3. Diabetes Mellitus Type-I, Acromegaly, Cushingâ??s syndrome and pancreatic disorder. 4. Those who are under insulin therapy. 5. Pregnant and lactating mothers. 6. Patients with acute complications like hyperglycemic coma, ketoacidosis and infections like gangrene. 7. Patients with K/C/O Nephropathy, Neuropathy and retinopathy. 8. Patients with gastrointestinal diseases, Liver diseases, tumors, conditions like cardiovascular disease, acute myocardial infarction, immune-compromised disease(HIV)

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Amruta Guggulu in Madhumeha.Timepoint: 3 months	—

Secondary

Measure	Time frame
1) To evaluate the efficacy of Amruta Guggulu in on the basis of subjective parameters in Madhumeha. 2)To evaluate the efficacy of Amruta guggulu in reducing the elevated Blood Sugar Levels in fasting state in Madhumeha. 3) To evaluate the efficacy of Amruta Guggulu in reducing the elevated Blood Sugar Levels in post prandial state in Madhumeha. 4) To evaluate the efficacy of Amruta Guggulu in achieving glycemic control on the basis of HbA1C in Madhumeha.Timepoint: 3 months	—

Measure

Time frame

1) To evaluate the efficacy of Amruta Guggulu in on the basis of subjective parameters in Madhumeha. 2)To evaluate the efficacy of Amruta guggulu in reducing the elevated Blood Sugar Levels in fasting state in Madhumeha. 3) To evaluate the efficacy of Amruta Guggulu in reducing the elevated Blood Sugar Levels in post prandial state in Madhumeha. 4) To evaluate the efficacy of Amruta Guggulu in achieving glycemic control on the basis of HbA1C in Madhumeha.Timepoint: 3 months

—

Countries

India

Contacts

Public ContactDr Amirhamja Salim Attar

M.A.Ms Sumatibhai Shah Ayurved Mahavidyalaya

amirhamjaattar58@gmail.com8421229824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026